Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
The latest update is out from CardieX Limited ( (AU:CDX) ).
CardieX Limited reported its quarterly cash flow, highlighting a net cash outflow from operating activities primarily due to substantial staff and administration costs. Despite the operational cash deficit, the company secured significant financing through equity securities and a funding commitment agreement, resulting in a net positive cash flow, which could bolster its financial position and support ongoing operations.
More about CardieX Limited
CardieX Limited operates in the healthcare technology industry, focusing primarily on developing cardiovascular and related medical devices. Its products aim to provide innovative solutions for monitoring and managing heart health, targeting both consumer and clinical markets.
YTD Price Performance: 0%
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $34M
Find detailed analytics on CDX stock on TipRanks’ Stock Analysis page.
